Publications 2001

  1. Boksa, J.; Mokrosz, M. J.; Charakchieva-Minol, S.; Tatarczyńska, E.; Kłodzińska, A.; Wesołowska, A.; Misztal, S. 2-H- and 2-acyl-9-{ω-[4-(2-methoxypheny)piperazinyl]-alkyl}-1,2,3,4-tetrahydro-β-carbolines as ligands of 5-HT 1A and 5-HT2A receptors. Pol. J. Pharmacol. 2001, 53, 501-508 (http://www.ncbi.nlm.nih.gov/pubmed/11990069).
  2. Bojarski, A. J.; Misztal, S.; Boksa, J.; Charakchieva-Minol, S.; Wesołowska, A.; Tatarczyńska, E.; Kłodzińska, A.; Chojnacka-Wójcik, E. Substituted 2-(1,2,3,4-tetrahydroisoquinoline)-butyl derivatives of azaspiro[4.5]decane-7,9-dione and phthalimide as new 5-HT1A and 5-HT2A receptor ligands. Med. Chem. Res. 2001, 10, 634-643.
  3. Bojarski, A. J.; Mokrosz, M. J.; Charakchieva-Minol, S.; Kozioł, A.; Wesołowska, A.; Tatarczyńska, E.; Kłodzińska, A.; Chojnacka-Wójcik, E. The Influence of Substitution at Aromatic Part of 1,2,3,4-Tetrahydroisoquinoline on in vitro and in vivo 5-HT1A/5-HT2A Receptor Activities of Its 1-Adamantoyloaminoalkyl Derivatives. Bioorg. Med. Chem. 2002, 10, 87-95 (http://www.ncbi.nlm.nih.gov/pubmed/11738610).
  4. Byrtus, H.; Pawłowski, M.; Duszyńska, B.; Wesołowska, A. ; Chojnacka-Wójcik, E.; Bojarski, A. J. Arylpiperazine derivatives of 3-propyl-β-tetralonohydantoin as new 5-HT1A and 5-HT2A receptor ligands. Pol. J. Pharmacol. 2001, 53, 395-401 (http://www.ncbi.nlm.nih.gov/pubmed/11990087).
  5. Paluchowska, M. H.; Bugno, R.; Charakchieva-Minol, S.; Bojarski, A. J.; Wesołowska, A. Substitution mode of the amide fragment in some new N-{ω-[4-(2-methoxyphenyl)piperazin-1-yl]alkyl}pyrid-2(1H)-ones and their 5-HT1A/5-HT2A activity. Pol. J. Pharmacol. 2001, 53, 369-376 (http://www.ncbi.nlm.nih.gov/pubmed/11990083).
  6. Chłoń, G.; Pawłowski, M.; Duszyńska, B.; Szaro, A.; Tatarczyńska, E.; Kłodzińska, A.; Chojnacka-Wójcik, E. Synthesis, 5-HT1A and 5-HT2A receptor activity of new 1-phenylpiperazinylpropyl derivatives with arylalkyl substituents in position 7 of purine-2,6-dione. Pol. J. Pharmacol. 2001, 53, 359-368 (http://www.ncbi.nlm.nih.gov/pubmed/11990082).
  7. Kowalski, P.; Kowalska, T.; Mokrosz, M. J.; Bojarski, A. J.; Charakchieva-Minol, S. Biologically Active 1-Arylpiperazines. Synthesis of New N-(4-Aryl-1-piperazinyl)alkyl Derivatives of Quinazolidin-4(3H)-one, 2,3-Dihydrophthalazine-1,4-dione and 1,2-Dihydropyridazine-3,6-dione as Potential Serotonin Receptor Ligands. Molecules 2001, 6, 784-795 (http://www.mdpi.com/1420-3049/6/9/784).
  8. Antkiewicz-Michaluk, L.; Michaluk, J.; Mokrosz, M.; Romanska, I. ; Lorenc-Koci, E.; Ohta, S.; Vetulani, J. Different action on dopamine catabolic pathways of two endogenous 1,2,3,4-tetrahydroisoquinolines with similar antidopaminergic properties. J. Neurochem. 2001, 78, 100-108 (http://www.ncbi.nlm.nih.gov/pubmed/11432977).
  9. Mokrosz, M. J.; Charakchieva-Minol, S.; Koziol, A.; Klodzinska, A.; Chojnacka-Wojcik, E. Influence of the terminal amide fragment geometry in some 3-arylideneindolin-2(1H)-ones on their 5-HT1A/5-HT2A receptor activity. Bioorg. Med. Chem. Lett. 2001, 11, 1229-1231 (http://www.ncbi.nlm.nih.gov/pubmed/11354383).
  10. Duszyńska, B.; Misztal, S. Ligandy receptorów serotoninowych w terapii migreny. Wiad. Chem. 2001, 55, 45-66 (http://yadda.icm.edu.pl/yadda/element/bwmeta1.element.baztech-article-BUS1-0010-0003).
  11. Karolak-Wojciechowska, J.; Fruzinski, A.; Mokrosz, M. J. Structure and conformational analysis of new arylpiperazines containing n-butyl chain. J. Mol. Struc. (Teochem) 2001, 542, 47-56 (http://www.sciencedirect.com/science/article/pii/S0166128000008022).
  12. Mokrosz, M. J.; Charakchieva-Minol, S.; Kowalski, P. Benzolactam derivatives and their affinity for alpha and alpha 2-adrenoreceptors. Arch. Pharm. (Weinheim) 2001, 334, 25-26 (http://www.ncbi.nlm.nih.gov/pubmed/11218574).